Charles E. Mowbray

2.8k citations
51 papers · 1.8k indexed · 1 hit paper · h-index 21
Topics
Research on Leishmaniasis Studies (22 papers)Trypanosoma species research and implications (19 papers)Synthesis and Biological Evaluation (10 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaNature Reviews Drug Discovery

In The Last Decade

Charles E. Mowbray

49 papers receiving 1.8k citations

Hit Papers

Hit and lead criteria in drug discovery for infectious di...20152026201820222015100200300400

Peers

Charles E. Mowbray
Comparison fields: 5 of 91
  • Public Health, Environmental and Occupational Health 810
  • Organic Chemistry 795
  • Epidemiology 637
  • Molecular Biology 406
  • Infectious Diseases 319
Replace Lyn‐Marié Birkholtz with:
Lyn‐Marié Birkholtz South Africa
Francisco‐Javier Gamo Spain
Radim Nencka Czechia
Mariano Zalis Brazil
Silvia Parapini Italy
Livia Vivas United Kingdom
Pedro Cravo Portugal
Tina S. Skinner‐Adams Australia
Victoria Barton United Kingdom
Lucia Gerena United States
Charles E. Mowbray relative to Lyn‐Marié Birkholtz South Africa Lyn‐Marié Birkholtz's profile →
Citations per field
00.5×3.7×
Lyn‐Marié Birkholtz · 1×
Citations per year

Countries citing papers authored by Charles E. Mowbray

Since Specialization
Citations

This map shows the geographic impact of Charles E. Mowbray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Mowbray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Mowbray more than expected).

Fields of papers citing papers by Charles E. Mowbray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Mowbray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Mowbray. The network helps show where Charles E. Mowbray may publish in the future.

Co-authorship network of co-authors of Charles E. Mowbray

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Mowbray. A scholar is included among the top collaborators of Charles E. Mowbray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Mowbray. Charles E. Mowbray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 1
5 1
6 34
7 5
8 11
9 5
10 55
11 20
12
Hit and lead criteria in drug discovery for infectious diseases of the developing worldbreakdown →
431
13 74
14 14
15 29
16 8
17 30
18 24
19 8
20 16

About Charles E. Mowbray

Charles E. Mowbray is a scholar working on Virology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (22 papers), Trypanosoma species research and implications (19 papers) and Synthesis and Biological Evaluation (10 papers). The work is most often cited by research in Organic Chemistry (795 citations), Public Health, Environmental and Occupational Health (810 citations) and Virology (109 citations). Charles E. Mowbray has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Jeremy N. Burrows, Takushi Kaneko, Rob Hooft van Huijsduijnen, Kiyoshi Kita, Peter Warner, Dennis M. Schmatz, Ken Duncan, Stéphanie Braillard, Manos Perros and Romuald Corbau. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026